Search
Eli Lilly Pins Hopes on Consumer - Centric Strategy, Anticipating a Major Leap for Weight - Loss Drugs in the U.S. Market
4 day ago /
Read about 0 minute
Author：小编
On Wednesday, the president of Eli Lilly's international operations informed Reuters that the company has already established a strong foothold in the obesity drug market across Europe, Asia, and the Middle East. Now, it's aiming to take its dominant edge in the U.S. market and expand it on a global level. President Patrick Jonsson mentioned that Eli Lilly is implementing a 'consumer - centric' business approach globally, akin to what it has been doing in the U.S. This includes forging partnerships with telemedicine and digital platforms. The goal is to cater to self - paying patients who are purchasing weight - loss drugs in diverse regions, spanning from the UK and China to the UAE.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
